中文名称: | 氯沙坦钾 促销 | ||||
---|---|---|---|---|---|
英文名称: | Losartan potassium | ||||
别名: | (1-((2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-2-丁基-4-氯-1H-咪唑基-5-基)甲基醇单钾 DuP-753 potassium | ||||
CAS No: | 124750-99-8 | 分子式: | C22H22ClKN6O | 分子量: | 461 |
CAS No: | 124750-99-8 | ||||
分子式: | C22H22ClKN6O | ||||
分子量: | 461 | ||||
MDL: | MFCD02092704 |
基本信息
产品编号: |
L10419 |
||||
产品名称: |
Losartan potassium |
||||
CAS: |
124750-99-8 |
储存条件 |
粉末 |
室温 |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
461.00 |
-20℃ |
1个月 |
||
化学名: |
|||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
92mg/mL (199.12mM) |
|||
Ethanol |
92mg/mL (199.12mM) |
||||
Water |
92mg/mL (199.12mM) |
||||
体内(现配现用): |
Saline |
30mg/mL |
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.1645mL |
10.8223mL |
21.6446mL |
5mM |
0.4329mL |
2.1645mL |
4.3289mL |
10mM |
0.2164mL |
1.0822mL |
2.1645mL |
50mM |
0.0433mL |
0.2164mL |
0.4329mL |
生物活性
产品描述 |
一种血管紧张素 II 受体 1 型 (AT1)拮抗剂,与血管紧张素 II 与 AT1 的结合竞争,IC50 为 20nM。 |
靶点 |
AT1 receptor |
20nM |
|
体外研究 |
Losartan competes with the binding of angiotensin II to AT1 receptors.The concentration that inhibits 50% of the binding of angiotensin II (IC50) is 20nM.Losartan (40μM) affects ISC but prevents the effect of ANGII on ISC.Losartan significantly reduces Ang II-mediated cell proliferation in endometrial cancer cells.The combination of losartan and anti-miR-155 has a significantly greater antiproliferative effect compared to each drug alone. |
体内研究 |
Losartan (0.6g/L,p.o.) -treated Fbn1C1039G/+mice show a reduction in distal airspace caliber relative to placebo-treated Fbn1C1039G/+animals.The doses of losartan and propranolol are titrated to achieve comparable hemodynamic effects.Analysis of pSmad2 nuclear staining reveals that losartan antagonizes TGF-β signaling in the aortic wall of Fbn1C1039G/+mice.Losartan can improve disease manifestations in the lungs,an event that cannot plausibly relate to improved hemodynamics.Losartan (10mg/kg,intraarterial injection) increases blood angiotensin levels four- to sixfold.Losartan (10mg/kg,i.p.) increases plasma renin levels 100-fold;plasma angiotensinogen levels decreases to 24% of control;and plasma aldosterone levels are unchanged. |
推荐实验方法(仅供参考)
细胞实验: |
|
An MTT assay is used to measure cell proliferation and viability.For the assay,5000 cells in 200μL media per well are seeded in a 96 well plate.After overnight incubation to allow for cell attachment,the medium is removed by suction.MTT at 1mg/mL concentration in serum-free medium is added and then incubated for 4 h at 37℃.After removal of MTT solution,100μL of DMSO is added to dissolve formazan crystals.Absorbance at 570nm and at 600nm as a reference is then measured using a microplate reader.The difference in absorbance is thus relative to the extent of cell survival. |
动物实验: |
|
Female Fbn1C1039G/+mice undergo timed matings with wild-type male mice.At 14.5d post-coitum,pregnant female Fbn1 C1039G/+mice are treated with oral losartan (0.6g/L in drinking water;n=10),propranolol (0.5g/L;n=6) or placebo (n=12).Therapy is continued throughout lactation and after weaning until 10 months of age.Mice are sacrificed and examined using the techniques described above.Propranolol is used for comparison with losartan because β-adrenergic receptor blockade is the current albeit controversial standard of care to modulate abnormal growth of the aortic root in MFS.Beginning at 7 weeks of age,wild-type and Fbn1C1039G/+mice are treated with oral losartan (0.6g/L in drinking water;n=5),propranolol (0.5g/L;n=7) or placebo (n=10).Mice are continued on oral therapy for 6 months and then sacrificed. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )